de La Coste A - Search Results

1

The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.

Terradillos O, de La Coste A, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, Gougeon ML, Kahn A, Buendia MA. Terradillos O, et al. Among authors: de la coste a. Oncogene. 2002 Jan 17;21(3):377-86. doi: 10.1038/sj.onc.1205110. Oncogene. 2002. PMID: 11821950

2

Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.

Renard CA, Fourel G, Bralet MP, Degott C, De La Coste A, Perret C, Tiollais P, Buendia MA. Renard CA, et al. Among authors: de la coste a. Oncogene. 2000 May 18;19(22):2678-86. doi: 10.1038/sj.onc.1203617. Oncogene. 2000. PMID: 10851067

3

Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes.

Mignon A, Guidotti JE, Mitchell C, Fabre M, Wernet A, De La Coste A, Soubrane O, Gilgenkrantz H, Kahn A. Mignon A, et al. Among authors: de la coste a. Nat Med. 1998 Oct;4(10):1185-8. doi: 10.1038/2681. Nat Med. 1998. PMID: 9771754

4

Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.

de la Coste A, Fabre M, McDonell N, Porteu A, Gilgenkrantz H, Perret C, Kahn A, Mignon A. de la Coste A, et al. Am J Physiol. 1999 Sep;277(3):G702-8. doi: 10.1152/ajpgi.1999.277.3.G702. Am J Physiol. 1999. PMID: 10484397

5

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. de La Coste A, et al. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51. doi: 10.1073/pnas.95.15.8847. Proc Natl Acad Sci U S A. 1998. PMID: 9671767 Free PMC article.

6

Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.

de La Coste A, Mignon A, Fabre M, Gilbert E, Porteu A, Van Dyke T, Kahn A, Perret C. de La Coste A, et al. Cancer Res. 1999 Oct 1;59(19):5017-22. Cancer Res. 1999. PMID: 10519417

7

Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells.

Morel A, Fernandez N, de La Coste A, Haddada H, Viguier M, Polla BS, Antoine B, Kahn A. Morel A, et al. Among authors: de la coste a. Cancer Immunol Immunother. 1998 Jul;46(5):277-82. doi: 10.1007/s002620050488. Cancer Immunol Immunother. 1998. PMID: 9690456 Free PMC article.

8

Does preventive vaccination with engineered tumor cells work in cancer-prone transgenic mice?

Morel A, de La Coste A, Fernandez N, Berson A, Kaybanda M, Molina T, Briand P, Haddada H, Guillet JG, Antoine B, Viguier M, Kahn A. Morel A, et al. Among authors: de la coste a. Cancer Gene Ther. 1998 Mar-Apr;5(2):92-100. Cancer Gene Ther. 1998. PMID: 9570300

9

In vivo and in absence of a thymus, the enforced expression of the Notch ligands delta-1 or delta-4 promotes T cell development with specific unique effects.

de La Coste A, Six E, Fazilleau N, Mascarell L, Legrand N, Mailhé MP, Cumano A, Laâbi Y, Freitas AA. de La Coste A, et al. J Immunol. 2005 Mar 1;174(5):2730-7. doi: 10.4049/jimmunol.174.5.2730. J Immunol. 2005. PMID: 15728481

10

Notch signaling: distinct ligands induce specific signals during lymphocyte development and maturation.

de La Coste A, Freitas AA. de La Coste A, et al. Immunol Lett. 2006 Jan 15;102(1):1-9. doi: 10.1016/j.imlet.2005.06.014. Epub 2005 Jul 18. Immunol Lett. 2006. PMID: 16140393 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters